CN Stock MarketDetailed Quotes

600285 Henan Lingrui Pharmaceutical

Watchlist
  • 23.92
  • -0.18-0.75%
Trading Jun 20 14:41 CST
13.57BMarket Cap22.09P/E (TTM)

Henan Lingrui Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Henan Lingrui Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

909.05M

+15.27%
EPS(YoY)

0.34

+32.28%
Analyst Rating

Strong Buy

Jun 20, 2024

Henan Lingrui Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.321B--
--2024/FY-- / 3.749B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--
--2019/FY2.157B / ----
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 4.321B--
--2024/FY-- / 3.749B--
--2023/FY3.311B / 3.455B--
--2022/FY3.002B / 3.146B--
--2021/FY2.694B / 2.780B--
--2019/FY2.157B / ----
--------
--------
--------
--------

Unlock Free Earnings Estimates

Henan Lingrui Pharmaceutical Earnings Reports

  • Ling Rui Pharmaceutical's 2024 First Quarter Report

    Apr 25 12:00 ET

  • Summary of Ling Rui Pharmaceutical's 2023 Annual Report

    Apr 25 12:00 ET

  • Ling Rui Pharmaceutical 2023 Annual Report

    Apr 25 12:00 ET

  • Lingrui Pharmaceutical\'s report for the third quarter of 2023

    Oct 27, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 20, 2024

    Strong Buy

    • Strong Buy

      81.82%

    • Buy

      18.18%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg